Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 333-338

  Toh, Yasushi ^a   Yamamoto, Manabu ^a   Endo, Kazuya ^a   Ikeda, Yasuharu ^a   Baba, Hideo ^a   Kohnoe, Shunji ^a   Yonemasu, Hirotoshi ^a   Hachitanda, Yoichi ^a   Okamura, Takeshi ^a   Sugimachi, Keizo ^b  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cancer progression; Carcinogenesis; Esophageal squamous cell carcinoma; Histone acetylation; Histone deacetylase 1

Indexed keywords

HDAC1 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE;

ACETYLATION; ARTICLE; CANCER INVASION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYMOLOGY; ESOPHAGUS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ACETYLATION; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HISTONES; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM INVASIVENESS;

EID: 18544407752     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.333     Document Type: Article

References (30)

1. Grunstein M: Histone acetylation in chromatin structure and transcription. Nature 389: 349-352, 1997.
2. Hassig CA and Schreiber SL: Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol 1: 300-308, 1997. (Pubitemid 127437155)
3. Wade PA and Wolffe AP: Histone acetyltransferases in control. Curr Biol 7: R82-R84. 1997.
4. Ayer DE: Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol 9: 193-198, 1999. (Pubitemid 29192987)
5. Taunton J, Hassig CA and Schreiber SL: A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272: 408-411, 1996. (Pubitemid 26138177)
6. Gray SG and Ekstrom TJ: The human histone deacetylase family. Exp Cell Res 262: 84-94, 2001.
7. Wang C, Fu M, Mani S, Wadier S, Senderowicz AM and Pesteil RG: Histone acetylation and the cell-cycle in cancer. Front Biosci 6: 610-629, 2001.
8. Cress WD and Seto E: Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184: 1-16, 2000. (Pubitemid 30349623)
9. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH and Nakatani Y: A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 345-364, 1996.
10. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601, 1998. (Pubitemid 28157603)
11. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain J.P, Troalen F, Trouche D and Harel-Bellan A: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601-605, 1998. (Pubitemid 28157604)
12. Marks PA, Richon VM and Rifkind RA: Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 692: 1210-1216, 2000. (Pubitemid 30627729)
13. Marks PA, Rifkind RA, Richon VM and Breslow R: Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 7: 759-760, 2001. (Pubitemid 32708707)
14. Toh Y, Pencil SD and Nicolson GL: A novel candidate metastasis-associated gene, mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269: 22958-22963, 1994.
15. Toh Y, Oki E, Oda S, Tokunaga E, Ohno S, Maehara Y, Nicolson GL and Sugimachi K: Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer 74: 459-463, 1997. (Pubitemid 27400170)
16. Toh Y, Kuwano H, Mori M, Nicolson GL and Sugimachi K: Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79: 1723-1726, 1999. (Pubitemid 29132295)
17. Zhang Y, LeRoy G, Seelig HP, Lane WS and Reinberg D: The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95: 279-289, 1998. (Pubitemid 28473788)
18. Toh Y, Kuninaka S, Endo K, Oshiro T, Ikeda Y, Nakashima H, Baba H, Kohnoe S, Okamura T, Nicolson GL and Sugimachi K: Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res 19: 105-111, 2000. (Pubitemid 30305528)
19. Xue Y, Wong J, Moreno GT, Young MK, Cote J and Wang W: NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2: 851-861, 1998. (Pubitemid 128378992)
20. Archer SY and Hodin RA: Histone acetylation and cancer. Curr Opin Genet Dev 9: 171-174, 1999. (Pubitemid 29158551)
21. Phillips AC and Vousden KH: Acetyltransferases and tumour suppression. Breast Cancer Res 2: 244-246, 2000. (Pubitemid 32223592)
22. Timmermann S, Lehrmann H, Polesskaya A and Harel-Bellan A: Histone acetylation and disease. Cell Mol Life Sei 58: 728-736, 2001. (Pubitemid 32553030)
23. Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T and Miyaki M: p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12: 1565-1569, 1996. (Pubitemid 26132043)
24. Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T and Caidas C: Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24: 300-303, 2000. (Pubitemid 30132203)
25. Gu W, Shi XL and Roeder RG: Synergistic activation of transcription by CBP and p53. Nature 387: 819-823, 1997. (Pubitemid 27270909)
26. Gu W and Roeder RG: Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606, 1997. (Pubitemid 27357952)
27. Wang LD, Hong JY, Qiu SL, Gao H and Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53: 1783-1787, 1993. (Pubitemid 23127103)
28. Yasuda M, Kuwano H, Watanabe M, Toh Y, Ohno S and Sugimachi K: p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis. Br J Cancer 83: 1033-1038, 2000.
29. Archer SY, Meng S, Shei A and Hodin RA: p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sei USA 95: 679-686, 1998.
30. Butler LM, Webb Y, Agus DB, Higgins B, Tolentino TR, Kutko MC, LaQuaglia MP, Drobnjak M, Cordon-Cardo C, Scher HI, Breslow R, Richon VM, Rifkind RA and Marks PA: Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res 7: 962-970, 2001. (Pubitemid 32708735)